SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

Health Canada Approves Ocrevus for Pediatric Multiple Sclerosis

Health Canada approved the intravenous formulation of Ocrevus for treating pediatric relapsing-remitting multiple sclerosis.

Related stories